You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

TECHNETIUM TC-99M TETROFOSMIN KIT - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for technetium tc-99m tetrofosmin kit and what is the scope of patent protection?

Technetium tc-99m tetrofosmin kit is the generic ingredient in two branded drugs marketed by Ge Healthcare and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Technetium tc-99m tetrofosmin kit has eight patent family members in seven countries.

One supplier is listed for this compound.

Summary for TECHNETIUM TC-99M TETROFOSMIN KIT
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for TECHNETIUM TC-99M TETROFOSMIN KIT
Generic Entry Date for TECHNETIUM TC-99M TETROFOSMIN KIT*:
Constraining patent/regulatory exclusivity:
Dosage:
INJECTABLE;INJECTION

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for TECHNETIUM TC-99M TETROFOSMIN KIT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ferozsons Laboratories Ltd.Phase 4

See all TECHNETIUM TC-99M TETROFOSMIN KIT clinical trials

US Patents and Regulatory Information for TECHNETIUM TC-99M TETROFOSMIN KIT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare MYOVIEW technetium tc-99m tetrofosmin kit INJECTABLE;INJECTION 020372-001 Feb 9, 1996 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ge Healthcare MYOVIEW 30ML technetium tc-99m tetrofosmin kit INJECTABLE;INJECTION 020372-002 Jul 7, 2005 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for TECHNETIUM TC-99M TETROFOSMIN KIT

Country Patent Number Title Estimated Expiration
Japan 5764328 ⤷  Try a Trial
China 101861170 Improved radiopharmaceutical composition ⤷  Try a Trial
Japan 2010539222 ⤷  Try a Trial
United Kingdom 0718386 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 2009037336 ⤷  Try a Trial
Spain 2562441 ⤷  Try a Trial
European Patent Office 2190484 COMPOSITION RADIOPHARMACEUTIQUE AMÉLIORÉE (IMPROVED RADIOPHARMACEUTICAL COMPOSITION) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for TECHNETIUM TC-99M TETROFOSMIN KIT

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1178838 300736 Netherlands ⤷  Try a Trial PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.